Actively Recruiting
A Personalised Approach Utilising the Frailty Index to Empower Consumers to Make Informed Decisions About Having a Colonoscopy to Avoid Low Value Care. A Prospective Randomized Controlled Trial.
Led by Princess Alexandra Hospital, Brisbane, Australia · Updated on 2025-08-01
200
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Frailty is a common condition in older adults that can increase the risk of poor health outcomes such as falls, hospital stays, and death. This research aims to study how assessing frailty before a colonoscopy might affect patient satisfaction and the number of colonoscopies avoided. The study is a prospective randomized controlled trial involving patients over 65 years old at Princess Alexandra Hospital, comparing a personalized approach using a frailty assessment to standard care. Participants will be randomly assigned to one of two groups. One group will receive a personalized approach that includes a frailty assessment using tests like grip strength, sit-to-stand timing, balance, and gait speed, along with questionnaires about medical conditions. The gastroenterologist will discuss the results and risks with the patient to help decide about having a surveillance colonoscopy. The other group will receive standard care, which involves discussing the benefits and risks of colonoscopy without the frailty assessment. During the study, participants will complete satisfaction questionnaires at the time of consultation and within weeks after any colonoscopy procedure. Researchers will track how many patients choose to avoid colonoscopy after receiving information and will monitor colorectal cancer-related complications and other causes of death within five years. The study will assess how the personalized approach may impact decision-making and patient satisfaction with outpatient services related to colonoscopy care.
CONDITIONS
Brief Title
A Personalised Approach Utilising the Frailty Index to Empower Consumers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged over 65 years of age
- Ability to understand the study instructions and answering questionnaires
You will not qualify if you...
- Inability to consent or participate in the assessments (e.g. frailty assessment) that are required as part of this project.
- Lack of informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit (in-person or telehealth)
Duration - Up to 2 weeks after consultation
Participants receive either a personalised frailty assessment with structured information to support decision-making about surveillance colonoscopy, or standard care discussions about colonoscopy benefits and risks.
1 consultation visit with the treating Gastroenterologist
Duration - Up to 5 years
Participants are monitored for colorectal cancer related morbidity and non-colorectal cancer related mortality for up to 5 years after referral.
Follow-up assessments as per routine care
Trial Site Locations
Total: 1 location
1
Princess Alexandra Hospital
Woolloongabba, Queensland, Australia, 4212
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SCREENING
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here